data + articles · 2 listed
newest 2023spec sheet10 rows
2-FEA (2-fluoroethamphetamine) is the N-ethyl analog of 2-FA and a fluorinated stimulant in the amphetamine family. It is presumed to raise dopamine and norepinephrine to produce energy, focus and wakefulness, likely a bit less potent than its N-methyl relatives. It is an obscure research chemical with sparse human data, but it carries the standard stimulant risks.
- Increased energy and wakefulness
- Improved focus
- Mood lift
- Appetite suppression
- Raised heart rate and blood pressure
- Insomnia
- Anxiety and jitteriness
Mechanism
2-FEA is presumed to act on the and systems as a releasing agent and/or , elevating catecholamines to drive stimulation, focus, and arousal, with limited involvement. N-ethyl substitution in the amphetamine series typically softens potency and shifts the subjective profile relative to N-methyl compounds; because 2-FEA itself is lightly studied, its exact transporter activity is described conservatively by analogy to related fluoroamphetamines.
receptor fingerprint
()Presumed releasing agent / reuptake inhibitor
transporter (NET)Presumed releasing agent / reuptake inhibitor
Dosingtypical ranges, not medical advice
interested in protocols and clinical dosages? make an account to see them! ^_^
Safetyrisks and cautions, not medical advice
Like other amphetamine-type stimulants, 2-FEA is expected to raise heart rate and blood pressure and strain the cardiovascular system, suppress sleep and appetite, and invite compulsive redosing with an unpleasant comedown. It should not be combined with MAOIs or stacked with other stimulants. With little human data available, its potency and safety margin are poorly defined. Not medical advice.
Subjective profileweighing the evidence above
An obscure amphetamine analog with two citations to its name, which means its potency and safety margin are guesswork. The cardiovascular strain, sleep loss and compulsive redosing are not guesswork. There is no reason to pick this over a stimulant that has actually been studied.
Resources
This entry is here for reference.
Research
- 1.Pharmacology of MDMA- and Amphetamine-Like New Psychoactive Substances
- 2.New trends of new psychoactive substances (NPS)-infused chocolate: Identification and quantification of trace level of NPS in complex matrix by GC-MS and NMR
2 listed here; entry last updated July 2026
Reviews
My notesprivate to this device
FAQ
How does 2-FEA relate to 2-FA?
It is the N-ethyl analog of 2-FA and is presumed to share its dopamine/norepinephrine stimulant mechanism, likely somewhat less potent.
Is much known about it?
No. It is a rarely studied research chemical with little formal human pharmacology, so its profile is described cautiously by analogy.
Can it be combined with MAOIs?
No. Amphetamine-type stimulants plus MAOIs can cause dangerous blood-pressure spikes.
Adverse effects
- Raised heart rate and blood pressure
- Insomnia
- Anxiety and jitteriness
Notes and cautions
- Compulsive redosing and comedown